申请人:C4 Therapeutics, Inc.
公开号:US10660968B2
公开(公告)日:2020-05-26
This invention provides compounds that have spirocyclic E3 Ubiquitin Ligase targeting moieties (Degrons), which can be used as is or linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.
本发明提供了具有螺环 E3 泛素连接酶靶向基团(Degrons)的化合物,这些化合物可单独使用,也可与用于体内降解的蛋白质的靶向配体连接,本发明还提供了其使用方法和组合物及其制备方法。